Found 127 matching trials
Using ctDNA to Determine Therapies for Lung Cancer PHASE2 This is a study to look at whether the presence of circulating tumour DNA (...
Show More Location
Princess Margaret Cancer Centre
Learn More & Join Trial
Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial NA The goal of this interventional clinical trial is to compare the efficacy o...
Show More Location
Multiple Locations
Learn More & Join Trial
Minimal Residual Disease-guided Adjuvant Therapy for Gastric Cancer NA This is a single-arm, interventional study to explore the feasibility of ci...
Show More Status
Active Not Recruiting
Location
Qilu Hospital of Shandong Univertisy
Learn More & Join Trial
Temozolomide and Irinotecan in Patients With MGMT Silenced Colorectal Cancer After Adjuvant Chemotherapy PHASE2 Surgical resection is curative for 75% of stage II and 50% of stage III col...
Show More Location
Fondazione IRCCS Istituto Nazionale dei Tumori
Learn More & Join Trial
Predictive Biomarkers of Response to Checkpoint Inhibitors in Triple Negative Breast Cancer: a Multiomics Platform N/A Patients with stage II-III Triple negative breast cancer (TNBC) candidates ...
Show More Location
Vall d'Hebron Institute of Oncology
Learn More & Join Trial
Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC N/A This clinical trial aims to explore the minimal residual disease (MRD) stat...
Show More Location
The Second Affiliated The Second Affiliated Hospital of Air Force Medical University (Tangdu Hospital)
Learn More & Join Trial
Predictive Value of ctDNA for NED Status in mCRC and Its Utility in Guiding Therapeutic Intervention NA The goal of this clinical trial is to detect the prognostic value of longit...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E) PHASE2 In this study circulating tumor DNA (ctDNA) blood testing is used to detect...
Show More Location
Stanford University
Learn More & Join Trial
Multi-layer Data to Improve Diagnosis, Predict Therapy Resistance and Suggest Targeted Therapies in HGSOC NA Chemotherapy resistance is the greatest contributor to mortality in advance...
Show More Location
Turku University Hospital
Learn More & Join Trial
Signatera Assessment in Early-Stage Endometrial Cancer NA The goal of this clinical trial is to assess if circulating tumor DNA can g...
Show More Location
University of Alabama at Birmingham Hospital
Learn More & Join Trial